Quick Detail
Place of Origin
Brand Name
Jinlan
HS-CODE
-
Package & Delivery Lead Time
Package
1g,10g,20g,
Detailed Description
Description
Darolutamide is a second‑generation, oral androgen receptor (AR) antagonist with high affinity for the AR. It inhibits AR nuclear translocation, DNA binding, and AR‑mediated transcription, suppressing prostate cancer cell growth.
Approved Indications
- Non‑metastatic castration‑resistant prostate cancer (NM‑CRPC)
- Metastatic hormone‑sensitive prostate cancer (mHSPC)
Key Features
- High AR selectivity and strong anti‑tumor activity
- Low blood‑brain barrier penetration
- Minimal drug‑drug interactions
- Favorable safety profile
Applications
API, intermediates, reference standards for R&D, generic registration and commercial production.
China [CN] 
Click enlarge Image